Search This Blog

Wednesday, November 29, 2023

Altamira partial spin-off of Bentrio® completed to increase focus on RNA delivery

 

Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue

https://www.globenewswire.com/news-release/2023/11/29/2787904/0/en/Altamira-Therapeutics-Regains-Compliance-with-Nasdaq-Minimum-Stockholders-Equity-Requirement.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.